This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Feb;16(2):142-3.

doi: 10.1016/S1473-3099(15)00528-9. Epub 2016 Jan 26.

Treatment of visceral leishmaniasis: options and choice

Sujit K Bhattacharya¹, Aditya Prasad Dash²

Affiliations

Affiliations

¹ Glocal Hospital, Krishnanagore, West Bengal, India. Electronic address: sujitkbhattacharya@yahoo.com.
² Central University of Tamil Nadu, Thiruvarur, Tamil Nadu, India.

PMID: 26867454
DOI: 10.1016/S1473-3099(15)00528-9

Treatment of visceral leishmaniasis: options and choice

Sujit K Bhattacharya et al. Lancet Infect Dis. 2016 Feb.

. 2016 Feb;16(2):142-3.

doi: 10.1016/S1473-3099(15)00528-9. Epub 2016 Jan 26.

Authors

Sujit K Bhattacharya¹, Aditya Prasad Dash²

Affiliations

¹ Glocal Hospital, Krishnanagore, West Bengal, India. Electronic address: sujitkbhattacharya@yahoo.com.
² Central University of Tamil Nadu, Thiruvarur, Tamil Nadu, India.

PMID: 26867454
DOI: 10.1016/S1473-3099(15)00528-9

No abstract available

PubMed Disclaimer

Comment in

Treatment of visceral leishmaniasis: pitfalls and stewardship.
Dorlo TPC, Ostyn BA, Uranw S, Dujardin JC, Boelaert M. Dorlo TPC, et al. Lancet Infect Dis. 2016 Jul;16(7):777-778. doi: 10.1016/S1473-3099(16)30091-3. Lancet Infect Dis. 2016. PMID: 27352756 No abstract available.

Similar articles

Miltefosine for Indian visceral leishmaniasis.
Roca B. Roca B. N Engl J Med. 2003 Feb 27;348(9):857-8; author reply 857-8. N Engl J Med. 2003. PMID: 12608397 No abstract available.
Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine.
Kumar D, Ramesh V, Verma S, Ramam M, Salotra P. Kumar D, et al. Ann Trop Med Parasitol. 2009 Dec;103(8):727-30. doi: 10.1179/000349809X12554106963438. Ann Trop Med Parasitol. 2009. PMID: 20030997 No abstract available.
Visceral Leishmaniasis-Optimum Treatment Options in Children.
Sundar S, Agarwal D. Sundar S, et al. Pediatr Infect Dis J. 2018 May;37(5):492-494. doi: 10.1097/INF.0000000000001885. Pediatr Infect Dis J. 2018. PMID: 29280784 Free PMC article. Review.
Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.
Murray HW. Murray HW. Future Microbiol. 2010 Sep;5(9):1301-3. doi: 10.2217/fmb.10.92. Future Microbiol. 2010. PMID: 20860475 No abstract available.
Visceral leishmaniasis in children: a review.
Palumbo E. Palumbo E. Minerva Pediatr. 2010 Aug;62(4):389-95. Minerva Pediatr. 2010. PMID: 20940672 Review.

See all similar articles

Cited by

T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis.
Costa-Madeira JC, Trindade GB, Almeida PHP, Silva JS, Carregaro V. Costa-Madeira JC, et al. Front Immunol. 2022 May 2;13:835711. doi: 10.3389/fimmu.2022.835711. eCollection 2022. Front Immunol. 2022. PMID: 35585983 Free PMC article. Review.
Leishmania infantum and Leishmania braziliensis: Differences and Similarities to Evade the Innate Immune System.
Falcão Sde A, Jaramillo TM, Ferreira LG, Bernardes DM, Santana JM, Favali CB. Falcão Sde A, et al. Front Immunol. 2016 Aug 3;7:287. doi: 10.3389/fimmu.2016.00287. eCollection 2016. Front Immunol. 2016. PMID: 27536300 Free PMC article.
Development of monoclonal antibodies against axenic amastigotes of Leishmania infantum strain in Iran: implication for diagnosis of Kala-azar.
Nourizadeh E, Zargar SJ, Alimohammadian MH, Ajdary S, Mahdavi M. Nourizadeh E, et al. Iran J Basic Med Sci. 2018 Apr;21(4):388-394. doi: 10.22038/IJBMS.2018.25355.6264. Iran J Basic Med Sci. 2018. PMID: 29796222 Free PMC article.
Serological and Molecular Analysis of Leishmania Infection in Healthy Individuals from Two Districts of West Bengal, India, Endemic for Visceral Leishmaniasis.
Kaushal H, Bhattacharya SK, Verma S, Salotra P. Kaushal H, et al. Am J Trop Med Hyg. 2017 Jun;96(6):1448-1455. doi: 10.4269/ajtmh.16-0592. Am J Trop Med Hyg. 2017. PMID: 28719266 Free PMC article.
Donor acquired visceral leishmaniasis following liver transplantation.
Dhaliwal A, Chauhan A, Aggarwal D, Davda P, David M, Amel-Kashipaz R, Brown R, Dedicoat M, Clark F, Shah T, Elsharkawy AM, Ushiro-Lumb I, Chiodini P, El-Sherif O, Armstrong M, Ferguson JW. Dhaliwal A, et al. Frontline Gastroenterol. 2021 Jan 4;12(7):690-694. doi: 10.1136/flgastro-2020-101659. eCollection 2021. Frontline Gastroenterol. 2021. PMID: 34917328 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations